Machine learning and clinical validation identify programmed cell death-related diagnostic biomarkers for major depressive disorder
Year: 2026
Type: article
Study design: Observational Study
Abstract: Major depressive disorder (MDD) contributes to a major global mental health burden and is characterized by complex molecular mechanisms. Given the emerging roles of programmed cell death (PCD) in MDD, this study aimed to profile PCD-associated transcriptomic features and identify clinically relevant candidate biomarkers. MDD-associated differentially expressed genes (DEGs) were identified from a human prefrontal cortex transcriptomic dataset. Hub genes associated with PCD dysregulation in MDD were screened using gene set variation analysis (GSVA), weighted gene co-expression network analysis (WGCNA), protein–protein interaction (PPI) network analysis, and further prioritized through multiple machine learning approaches. Clinical blood-based validation was performed to assess the diagnostic relevance of the prioritized hub genes. A binary logistic regression model was constructed to combine these hub genes, and the joint diagnostic performance was evaluated using receiver operating characteristic (ROC) analysis. A total of 743 MDD-related DEGs were identified in the human prefrontal cortex, including 453 upregulated and 290 downregulated genes. GSVA revealed extensive alterations in PCD pathway activity in MDD, characterized by increased enrichment of methuosis, autophagy, cuproptosis, and apoptosis, together with decreased enrichment of several other PCD pathways. Subsequent analysis prioritized five candidate genes with diagnostic potential including HADHB, NDUFB7, ACADVL, NDUFAF4, and NDUFS7. Their encoded proteins exhibited markedly reduced abundance in the clinical blood cohort. A binary logistic regression model incorporating these genes achieved favorable diagnosistic power in the clinical cohort (AUC = 0.876; 95% CI: 0.784–0.969). This integrative analysis highlights the potential involvement of PCD dysregulation in MDD and nominates HADHB, NDUFB7, ACADVL, NDUFAF4, and NDUFS7 as promising PCD–mitochondria–depression (PMD) diagnostic signature genes. This multigene diagnostic signature demonstrated robust diagnostic performance, supporting its potential translational value as a blood-based diagnostic aid for MDD.
Source: BMC Psychiatry
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,290
OpenAlex ID: W7226041199
